drugset / Trial / NCT00556179

Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis

NCT00556179 ↗

Phase 4 Completed 122 enrolled Sanofi
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to demonstrate if the use of Dermacyd can avoid the recurrence of bacterial vaginosis after three months of the standard treatment.

Timeline

Start
2007-09
Primary completion
2008-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject lactoserum Unknown — —

Indications